spacer
home > epc > summer 2019 > the changing face of clinical data
PUBLICATIONS
European Pharmaceutical Contractor

The Changing Face of Clinical Data




Data collection and analysis have always been central to the development of new clinical interventions such as drug treatments, diagnostics, and medical devices. While clinical data have always been collected and analysed, in recent years emerging methods and technologies for collection, analysing and utilising data, as well as the sheer quantity of data collected have been changing, driven by innovation and an evolving drug development landscape.

Clinical data can take many forms, but are essentially any information collected about an individual over the course of their admission and treatment in a medical setting. These data can range from their medical record information (such as age and medical history), the clinical interventions they undergo (such as blood tests, drugs prescribed, and surgical procedures), and the resulting outcomes following an intervention. These measures form the basis of any clinical trial that seeks to establish the efficacy or safety of a novel drug treatment, medical device, or diagnostic.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Aiden Flynn is the Founder of Exploristics and has more than 20 years’ experience in drug discovery and clinical development. After seven years as a lecturer at University College London, UK, Aiden spent 10 years at GlaxoSmithKline as a Director of statistical support for biomarker studies across R&D. In recent years, he has worked closely with the FDA and EMEA to develop tools and guidelines that support the use of biomarkers in clinical studies. Since founding Exploristics in 2009, Aiden has attracted over 50% of the world’s top pharma companies as clients, as well as many biotechnology, device, and diagnostic companies.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

New offices at leading science hub support the Company’s rapid growth following recent investment New facility is in addition to headquarters at Babraham Research Campus, Cambridgeshire, UK and offices in Monmouth Junction, New Jersey, USA
More info >>

White Papers

Data Technology as a Catalyst for Growth in the Life Sciences

AIGENPULSE

The life sciences industry is changing at a rapid pace. The need to develop the next blockbuster is pushing current technologies and methodologies to the limit. Scientific advancement over the last decades was embossed with giant leaps in knowledge, however, the new reality is that smaller incremental gains need to be carved out with ever increasing investments. In order to survive, progress and prosper in this new reality, a holistic approach to getting the most of research data is crucial. In fact, it will likely be the difference of being in existence in 5-10 years or not. For those bold enough to step into an area they are unfamiliar with, huge rewards are waiting.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India forhigh quality, low   cost pharma solutions, CPhI & P-MEC Indiais the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India’s pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement